BioHealth News Archive
Viela Bio to be acquired by Horizon Therapeutics for $3.1 billion – Washington Business Journal
The move comes less than three years after the Gaithersburg biotech spun out of MedImmune. Image: Viela Bio CEO Bing Yao, pictured here on…
Read More
Meet the 9 ventures in Halcyon’s latest incubator program this spring – Technical.ly DC
Georgetown-based Halcyon Incubator has announced the 14th cohort for its incubator for early-stage social impact entrepreneurs. The 18-month fellowship welcomes nine ventures, majority of…
Read More
Workers Producing the Vaccine Need Vaccination – WSJ
In the race to vaccinate people for Covid-19, everyone agrees front-line health workers, the elderly and those with pre-existing conditions should get priority. But…
Read More
New Johns Hopkins report details plan for digital equity in Baltimore | Hub
The lack of reliable access to broadband internet service for many in Baltimore, particularly the poor, has profound economic and social consequences. The COVID-19…
Read More
Here are some of the fascinating predictions from Kurt Newman
Recently a colleague asked me to predict the future of pediatric #medicine in 30 years. To help develop my list, I tapped many of…
Read More
LifeBridge Health, Healthworx launch innovation incubator for health tech startups
Baltimore-based LifeBridge Health is partnering with Healthworx, the innovation and investment arm of CareFirst BlueCross BlueShield, to launch a new incubator for startup companies…
Read More
Wilmington digital health company Amalgam Rx acquired Avhana Health – Technical.ly Delaware
Wilmington’s Amalgam Rx, a digital medicine and patient support company, has acquired Baltimore-based Avhana Health. With the acquisition, which closed this month, Avhana’s seven employees…
Read More
Baltimore’s Catalio partners with New York investment firm HealthCor Management to launch blank check IPO – Baltimore Business Journal
A new “blank check” company created through a partnership between Baltimore venture capital firm Catalio Capital Management and New York investment firm HealthCor Management…
Read More
Emergent BioSolutions unveils 7th pandemic CDMO contract, this time for Humanigen’s late-stage antibody hopeful | FiercePharma
Manufacturing powerhouse Emergent BioSolutions unveiled its seventh COVID-19 CDMO tie-up Monday, this time to help crank out Humanigen’s late-stage antibody hopeful lenzilumab. Emergent will…
Read MoreHealthworx and LifeBridge Health Launch Startup Incubator: 1501 Health
Newswise — Healthworx, the innovation and investment arm of CareFirst BlueCross BlueShieldis partnering with LifeBridge Health to launch 1501 Health, an incubator for healthcare…
Read MoreOn Demand Pharmaceuticals picks Rockville for new HQ – Washington Business Journal
The move solidifies the company’s local presence about four months after it secured a temporary occupancy permit in September. Image: Ben Wu is CEO…
Read More
It’s not too soon to start thinking about the next pandemic | LinkedIn
One of the questions I get asked the most is when I think the world will get back to normal. I understand why. We…
Read More
Novavax Reports Varying Success vs. COVID-19 Variants
Novavax electrified investors last night by announcing that its COVID-19 vaccine NVX-CoV2373 showed efficacy of 89.3% in the company’s first analysis of data from…
Read More
GetWellNetwork scoops up Docent Health | MobiHealthNews
Patient engagement platform GetWellNetwork announced it has acquired patient-messaging company Docent Health for an undisclosed sum. As part of the deal, GetWellNetwork will be…
Read More
Emergent BioSolutions to make J&J COVID-19 vaccine in Baltimore
The Johnson & Johnson one-shot coronavirus vaccine is expected to be a game-changer in fighting COVID-19 -- and it will be made in Baltimore.…
Read More